Keyword: Johnson & Johnson

News

Bayer, Novartis said to Eye Merck & Co consumer health unit

21.02.2014 - A handful of consumer and healthcare companies including Germany's Bayer and Switzerland's Novartis are exploring a deal for Merck & Co's consumer healthcare business, people...

News

Drug Maker Boehringer Facing U.S. Lawsuits

20.02.2014 - German pharmaceutical producer Boehringer Ingelheim is being confronted in the U.S. with more than 2,000 lawsuits related to its blood thinner Pradaxa (dabigatran). The plaintiffs...

News

Carlyle Wins J&J Diagnostic Unit

17.01.2014 - As expected, U.S. private equity investor Carlyle has been given the nod to acquire the ortho clinical diagnostics unit of compatriot pharmaceutical producer Johnson & Johnson (J&J...

News

J&J Petitions FDA to Require ‘Similar’ Names For Biosimilars, Biologics

10.01.2014 - Johnson & Johnson on Wednesday said it submitted a citizen petition asking that U.S. health regulators require copies of biological products to bear names that are similar and not...

News

Carlyle Said Close to Buying J&J Diagnostics Unit

06.01.2014 - Private equity investor Carlyle is in exclusive talks to buy Johnson & Johnson's ortho clinical diagnostics unit for around $4 billion, after knocking Blackstone out of the race...

News

EU Fines Drugmakers €16 million for Painkiller Delay

13.12.2013 - The European Commission has fined U.S. pharmaceutical producer Johnson & Johnson (J&J) €10.8 million and Swiss drugmaker Novartis of Switzerland € 5.5 million for actions taken by...

News

J&J reaches $4 Billion Deal On Hip Implant Lawsuits

13.11.2013 - Johnson & Johnson will pay more than $4 billion to settle thousands of lawsuits over its recalled defective hip implants, Bloomberg reported late on Tuesday, citing three people...

News

Jesse Wu Named Chairman of J&J China

28.08.2013 - Johnson & Johnson said on Tuesday the business heads of its three Chinese operations would begin to report to one local chairman next month in an effort to increase sales and...